Sinaei Reza, Hosseininasab Ali, Abbaslou Parvin, Zeinali Mazyar, Iranmanesh Elham, Sinaei Roya, Rahmanian Keramat
Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
BMC Pediatr. 2025 Apr 17;25(1):308. doi: 10.1186/s12887-025-05599-4.
Gastrointestinal (GI) manifestations have been reported as the most extra-pulmonary manifestations of coronavirus disease 2019 (COVID-19). Recognizing the various manifestations, especially as presenting symptoms of COVID-19 is of great importance. We aimed to investigate the GI and hepatic manifestations of COVID - 19 in children, determining the factors associated with the disease severity and prognosis related to GI symptoms.
In this retrospective study, children aged 1-month to 16-years who were admitted to Afzalipour Hospital in Kerman, Iran. for a period of one year (from October 2020 to October 2021) with the diagnosis of COVID-19 were included. The comparison of clinical symptoms and laboratory variables in the appendectomy and non-appendectomy groups were evaluated. Patients' information was extracted from the patient's medical record and analyzed in SPSS statistical. software.
A total of 163 patients (107 boy and 56 girls) with mean age of 4.35 ± 3.86 (range 0.08 to 16) years were included. The most frequent GI symptoms at the time of admission were watery diarrhea (46.6%), vomiting (45.4%), and abdominal pain (32.5%). There was no significant relationship between clinical symptoms and laboratory variables in the appendectomy and non-appendectomy groups, but the severity of COVID-19 was significantly associated with appendicitis (P = 0.03). There was no statistically significant relationship between liver enzyme levels and disease severity and pediatric intensive care unit admission.
Although most COVID-19 patients present with GI manifestations, we could not determine the relationship between GI and hepatic manifestations and disease severity in this study.
Not applicable.
胃肠道(GI)表现已被报道为2019冠状病毒病(COVID-19)最常见的肺外表现。认识到这些各种表现,尤其是作为COVID-19的首发症状非常重要。我们旨在调查儿童COVID-19的胃肠道和肝脏表现,确定与疾病严重程度以及与胃肠道症状相关的预后因素。
在这项回顾性研究中,纳入了年龄在1个月至16岁之间、因COVID-19诊断于伊朗克尔曼的阿夫扎利普尔医院住院一年(从2020年10月至2021年10月)的儿童。评估了阑尾切除术组和非阑尾切除术组的临床症状和实验室变量的比较。患者信息从患者病历中提取,并在SPSS统计软件中进行分析。
共纳入163例患者(107例男孩和56例女孩),平均年龄为4.35±3.86(范围0.08至16)岁。入院时最常见的胃肠道症状是水样腹泻(46.6%)、呕吐(45.4%)和腹痛(32.5%)。阑尾切除术组和非阑尾切除术组的临床症状与实验室变量之间无显著关系,但COVID-19的严重程度与阑尾炎显著相关(P = 0.03)。肝酶水平与疾病严重程度和儿科重症监护病房入院之间无统计学显著关系。
尽管大多数COVID-19患者有胃肠道表现,但在本研究中我们无法确定胃肠道和肝脏表现与疾病严重程度之间的关系。
不适用。